A Cyst You Can’t Miss: A Rare Presentation of an Orbital Apocrine Hidrocystoma

Behshad, Soroosh; Weil, Natalie C.; Ho, Son; Mayhall, Greg; Valenzuela, Alejandra A.

doi:10.3109/01676830.2015.1014514

Cited by 4 publications

(12 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has been hypothesized that sequestration of epithelial cells at the embryonic stage or traumatic implantation of epithelial cells into deeper tissues, including orbit, could lead to the condition. In our case, the lesion was acquired and there was no history of trauma or any prior surgical procedures (3)(4)(5)(6)(7)(8) .…”

Section: Discussionmentioning

confidence: 83%

“…Apocrine hidrocystomas are benign cystic lesions derived from the sweat glands of Moll and seldom found in the orbit. In this case, we report an apocrine hidrocystoma found in the superomedial wall of the orbit (1)(2)(3)(4) . Although orbital cystic lesions are often encountered, they are mostly dermoid cysts and mucoceles.…”

Section: Discussionmentioning

confidence: 90%

“…idrocystomas are benign cystic lesions derived from sweat glands. Histologically, two types of hidrocystoma, eccrine and apocrine are recognized, reflecting the cells of origin (1)(2)(3) . Apocrine hidrocystomas are benign cystic lesions derived from the sweat glands of Moll and seldom found in the orbit.…”

mentioning

confidence: 99%

“…They are usually yellow-to-white (sometimes with layering) but less commonly blue to black (due to the Tyndall effect from the turbid contents), typically arise at the eyelid margins particularly around the inner canthus of the eyelid where the glands of Moll are located. Apocrine hidrocystomas are seldom found in the orbit (2)(3)(4)(5)(6) . The pathophysiology of hidrocystomas is uncertain.…”

mentioning

confidence: 99%

“…The pathophysiology of hidrocystomas is uncertain. It has been hypothesized that sequestration of epithelial cells at the embryonic stage or traumatic implantation of epithelial cells into deeper tissues, including orbit, could lead to the condition (2)(3) .…”

mentioning

confidence: 99%

See 4 more Smart Citations

Orbital apocrine hidrocystoma with immunohistochemical confirmation

Feijó¹,

Nery²,

Caiado³

et al. 2016

Revista Brasileira De Oftalmologia

View full text Add to dashboard Cite

Os autores relatam o primeiro caso de hidrocistoma apócrino orbitário com confirmação imunohistoquímica. O tumor apresentou crescimento lento e progressivo, sem relato de baixa de acuidade visual, diplopia, epífora, secreção ou trauma prévio. Não houve proptose ou alteração da motilidade extraocular. O exame de imagem por tomografia computadorizada da órbita revelou uma lesão nodular, extraconal, de limites imprecisos, com áreas císticas e sólidas no seu interior, na região súpero-medial de órbita direita. O paciente foi submetido à orbitotomia por via anterior, com exérese integral da tumoração. O exame histopatológico revelou o diagnóstico de hidrocistoma apócrino e a imunohistoquímica confirmou o diagnóstico. Após a cirurgia, o paciente teve regressão total dos sintomas. Descritores: Hidrocistoma/diagnóstico; Hidrocistoma/cirurgia; Órbita/cirurgia; Tomografia computadorizada por raios x; Imunohistoquímica; Relatos de casos

show abstract

Section: Discussionmentioning

confidence: 83%

Section: Discussionmentioning

confidence: 90%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Orbital apocrine hidrocystoma with immunohistochemical confirmation

Feijó¹,

Nery²,

Caiado³

et al. 2016

Revista Brasileira De Oftalmologia

View full text Add to dashboard Cite

show abstract

Multiple Eyelid Apocrine Hidrocystomas in a Patient With Prolactinoma

Akgoz,

Derin Sengun,

Dashdamirova

et al. 2024

Ophthalmic Plastic &Amp; Reconstructive Surgery

View full text Add to dashboard Cite

show abstract

Intraconal Orbital Hidrocystoma in an Infant

Bagheri

Veisi

Rikhtehgar

et al. 2020

Journal of Craniofacial Surgery

View full text Add to dashboard Cite

rate. Besides, the high dose use of TXA was significantly associated with an increase in seizure attacks. Likely, it was speculated that low-dose TXA as 10 mg/kg bolus injection followed by 1 mg/kg/h continuous infusion could achieve a large proportion of TXA efficacy. 7 In our study, compared to the previously reported literature, although there was a slight improvement in blood loss in TXA administered groups compared to the control group, no significant difference was observed regarding this parameter between the study groups. We may postulate that since the nasal cavity is small and the blood vessels are abundant, our results could be due to meticulous hemostatic control during the surgeries. Our results are similar to previous studies, which reported that postulated the use of TXA decreases postoperative blood loss. 12,13 It was reported that an IV dose of 10 mg/kg TXA produces a therapeutic blood concentration for 3 hours, while 20 mg/kg maintains the same effect for eighth hours. This shows that irrespective of the treatment, TXA acts mainly on fibrinolysis and not on primary coagulation. 13 A more extended infusion period may provide constant blood levels of TXA and reduce blood loss.Adverse effects of the systemic use of TXA are nausea, vomiting, deep vein thrombosis, pulmonary embolism, myocardial infarction, seizures, visual disturbances, and acute renal necrosis. 14 Our study observed no side effects since these unintended effects could be found in higher doses.The strength of our study was that the same surgeon performed all operations, and it was designed as a prospective randomized controlled study. However, our results might not be compatible with the previous studies due to the small sample size. Besides, we did not evaluate the most common surgery-related complications, such as eyelid edema and periorbital ecchymosis. A surgeon assessment score for the cleanness or visibility of the operation field also could be utilized. Further studies can be designed in rhinoplasty patients, taking into account our limitations or using an infusion of TXA instead of slow injection.In conclusion, the administration of single-dose IV and intermittent IV doses of TXA can decrease TBL and the number of blood transfusions required without complication in rhinoplasty surgery. But the statistical analysis and clinical relevance are not significant. TXA is a viable method of decreasing perioperative blood loss in rhinoplasty surgery with no complication. Further studies are required to find the ideal dosage and timing in ENT surgery.

show abstract

A Cyst You Can’t Miss: A Rare Presentation of an Orbital Apocrine Hidrocystoma

Cited by 4 publications

References 3 publications

Orbital apocrine hidrocystoma with immunohistochemical confirmation

Orbital apocrine hidrocystoma with immunohistochemical confirmation

Multiple Eyelid Apocrine Hidrocystomas in a Patient With Prolactinoma

Intraconal Orbital Hidrocystoma in an Infant

Contact Info

Product

Resources

About